HQ Function

The Exton headquarters served as the central hub for Idera's corporate operations, research and development oversight, clinical trial management, and business development activities before the company's acquisition.

Notable Features:

The facility was located within a modern office park, providing infrastructure suitable for administrative functions and the management of clinical-stage biopharmaceutical research programs.

Work Culture:

As a clinical-stage biopharmaceutical company, the work culture at Idera Pharmaceuticals likely emphasized innovation, scientific rigor, collaboration, and a strong patient-centric approach to drug development. Employees were typically driven by the mission to address unmet medical needs in challenging therapeutic areas like rare diseases and oncology.

HQ Significance:

The headquarters was crucial as the command center for Idera's strategic planning, financial operations, and the coordination of its clinical development programs for its novel TLR-targeting drug candidates worldwide.

Values Reflected in HQ: The headquarters' operations aimed to reflect values of scientific excellence, commitment to patients, and a drive for innovation in developing new medicines for serious diseases.

Location:

Prior to its acquisition by Aceragen, Idera Pharmaceuticals conducted and managed global clinical trials for its drug candidates. This involved operations across North America, Europe, and potentially other regions, depending on the specific trial requirements. Its global presence was primarily characterized by clinical trial site management, patient recruitment efforts, and interactions with regulatory authorities in various countries. The company also engaged in international business development activities to explore partnerships and licensing opportunities for its therapeutic programs.

Street Address:

505 Eagleview Boulevard, Suite 212

City:

Exton

State/Province:

Pennsylvania

Country:

USA